Rapamycin extends murine lifespan but has limited effects on aging
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Aging is a major risk factor for a large number of disorders and functional impairments. Therapeutic targeting of the aging process may therefore represent an innovative strategy in the quest for novel and broadly effective treatments against age-related diseases. The recent report of lifespan extension in mice treated with the FDA-approved mTOR inhibitor rapamycin represented the first demonstration of pharmacological extension of maximal lifespan in mammals. Longevity effects of rapamycin may, however, be due to rapamycin's effects on specific life-limiting pathologies, such as cancers, and it remains unclear if this compound actually slows the rate of aging in mammals. Here, we present results from a comprehensive, large-scale assessment of a wide range of structural and functional aging phenotypes, which we performed to determine whether rapamycin slows the rate of aging in male C57BL/6J mice. While rapamycin did extend lifespan, it ameliorated few studied aging phenotypes. A subset of aging traits appeared to be rescued by rapamycin. Rapamycin, however, had similar effects on many of these traits in young animals, indicating that these effects were not due to a modulation of aging, but rather related to aging-independent drug effects. Therefore, our data largely dissociate rapamycin's longevity effects from effects on aging itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some SASP inhibitors can have agent-specific off-target effects, for example, rapamycin, which can cause nephrotoxicity, metabolic impairment and susceptibility to infections, at least at higher doses in mice109.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rapamycin and its analogs (so-called ‘rapalogs’) suppress the SASP by inhibiting mTOR and appear to extend healthspan and lifespan in mice105,108,109.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study by Neff and colleagues found that rapamycin significantly reduced the proportion of 16 month old mice with cancer and/or precancerous lesions 87, and suggested that this indicated that the effects of rapamycin on lifespan was driven by its anti-cancer effects.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [87]
In the citing paper
“Studies have provided evidence that rapamycin only prolongs lifespan through antitumor mechanisms, thereby inhibiting the main pathological changes in mice [190, 191].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 10×
“Rapamycin treatment was essentially as previously described (9).”
InfluentialRegulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients
Kaeberlein, M., Powers, R. W., Steffen, K. K., Westman, E. A., Hu, D., Dang, N., Kerr, E. O., Kirkland, K. T., Fields, S., & Kennedy, B. K. (2005) · Science · doi:10.1126/science.1115535 · Cited by 1,293
Experience-Induced Neurogenesis in the Senescent Dentate Gyrus
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03206.1998 · Cited by 1,150 · cited 1×
“There is a known strong age-dependent decline in adult hippocampal neurogenesis (21).”
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120
Influence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Extension of Chronological Life Span in Yeast by Decreased TOR Pathway Signaling
Powers, R. W., Kaeberlein, M., Caldwell, S. D., Kennedy, B. K., & Fields, S. (2006) · Genes & Development · doi:10.1101/gad.1381406 · Cited by 982
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., et al. (2011) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq178 · Cited by 896
CellProfiler™: Free, Versatile Software for Automated Biological Image Analysis
Lamprecht, M. R., Sabatini, D. M., & Carpenter, A. E. (2007) · BioTechniques · doi:10.2144/000112257 · Cited by 895
Research works printed but not linked: 4
- Olshansky, 2006, Scientist., 20, 28
- Frith, 1980, Lab Anim Sci., 30, 835
- Coquelin, 1982, Am J Physiol., 243, E257
- Sommer C, Straehle C, Köthe U, Hamprecht FA. 8th IEEE International Symposium on Biomedical Imaging. March 30-April 2, 2011; Chicago, Illinois, USA.
Cited by
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Rapamycin: one drug, many effects
Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287
Spermidine in health and disease
Madeo, F., Eisenberg, T., Pietrocola, F., & Kroemer, G. (2018) · Science · doi:10.1126/science.aan2788 · Cited by 1,154
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Youm, Y.-H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.010 · Cited by 674
Aging and age‐related diseases: from mechanisms to therapeutic strategies
Li, Z., Zhang, Z., Ren, Y., Wang, Y., Fang, J., Yue, H., Ma, S., & Guan, F. (2021) · Biogerontology · doi:10.1007/s10522-021-09910-5 · Cited by 640
Miller, R. A., Harrison, D. E., Astle, C. M., Fernandez, E., Flurkey, K., Han, M., Javors, M. A., Li, X., Nadon, N. L., Nelson, J. F., et al. (2014) · Aging Cell · doi:10.1111/acel.12194 · Cited by 621
Immunosenescence: a key player in cancer development
Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00986-z · Cited by 510
The quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Essential role for autophagy in life span extension
Madeo, F., Zimmermann, A., Maiuri, M. C., & Kroemer, G. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73946 · Cited by 464
A synopsis on aging—Theories, mechanisms and future prospects
da Costa, J. P., Vitorino, R., Silva, G. M., Vogel, C., Duarte, A. C., & Rocha-Santos, T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.005 · Cited by 456
Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease
Sciarretta, S., Volpe, M., & Sadoshima, J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302022 · Cited by 453
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
mTOR in Brain Physiology and Pathologies
Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 356
Animal models of aging research: implications for human aging and age-related diseases
Mitchell, S. J., Scheibye-Knudsen, M., Longo, D. L., & de Cabo, R. (2015) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-110829 · Cited by 328
“This led to the discovery that rapamycin (named for its discovery on Easter Island, RapaNui), an inhibitor of mTOR,may be able to ameliorate aspects of the accelerated aging diseases Hutchinson-Gilford progeria and Cockayne syndrome (8, 9), as well as extending life span in mice (3, 10).”
BackgroundDai, D., Karunadharma, P. P., Chiao, Y. A., Basisty, N., Crispin, D., Hsieh, E. J., Chen, T., Gu, H., Djukovic, D., Raftery, D., et al. (2014) · Aging Cell · doi:10.1111/acel.12203 · Cited by 328
Molecular and biological hallmarks of ageing
Aunan, J. R., Watson, M. M., Hagland, H. R., & Søreide, K. (2016) · British Journal of Surgery · doi:10.1002/bjs.10053 · Cited by 318
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity
Seals, D. R., Justice, J. N., & LaRocca, T. J. (2016) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282665 · Cited by 312
Effect of rapamycin on aging and age-related diseases—past and future
Selvarani, R., Mohammed, S., & Richardson, A. (2021) · GeroScience · doi:10.1007/s11357-020-00274-1 · Cited by 290
Reduced Expression of MYC Increases Longevity and Enhances Healthspan
Hofmann, J. W., Zhao, X., De Cecco, M., Peterson, A. L., Pagliaroli, L., Manivannan, J., Hubbard, G. B., Ikeno, Y., Zhang, Y., Feng, B., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.016 · Cited by 293
“…et al., 2004); Ames dwarf, CR and rapamycin or metformin administration ameliorate cancer (Ikeno et al., 2003; Martin-Montalvo et al., 2013; Neff et al., 2013); and CR, Ames dwarf, and metformin-treated mice have better motor coordination (Brown-Borg et al., 2012; Lanza et al.,…”
InfluentialSirtuins: guardians of mammalian healthspan
Giblin, W., Skinner, M. E., & Lombard, D. B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.007 · Cited by 282
Making sense of the ageing methylome
Seale, K., Horvath, S., Teschendorff, A., Eynon, N., & Voisin, S. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00477-6 · Cited by 274
Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases
Ren, J., & Zhang, Y. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.10.005 · Cited by 268
Caloric restriction mimetics: towards a molecular definition
Madeo, F., Pietrocola, F., Eisenberg, T., & Kroemer, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4391 · Cited by 245
Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
Arriola Apelo, S. I., & Lamming, D. W. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw090 · Cited by 239
Autophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 225
Spermidine: A physiological autophagy inducer acting as an anti-aging vitamin in humans?
Madeo, F., Bauer, M. A., Carmona-Gutierrez, D., & Kroemer, G. (2019) · Autophagy · doi:10.1080/15548627.2018.1530929 · Cited by 212
Sharples, A. P., Hughes, D. C., Deane, C. S., Saini, A., Selman, C., & Stewart, C. E. (2015) · Aging Cell · doi:10.1111/acel.12342 · Cited by 201
Chiao, Y. A., & Rabinovitch, P. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025148 · Cited by 200
“Rapamycin treatment for 1 yr initiated at mid-life attenuated the increased LV dimensions in aged hearts, but failed to show any effect on systolic function in male mice (Neff et al. 2013).”
BackgroundInhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
Lamming, D. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025924 · Cited by 195
Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning
Liu, D., Bordicchia, M., Zhang, C., Fang, H., Wei, W., Li, J.-L., Guilherme, A., Guntur, K., Czech, M. P., & Collins, S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83532 · Cited by 193
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
Umemura, A., Park, E. J., Taniguchi, K., Lee, J. H., Shalapour, S., Valasek, M. A., Aghajan, M., Nakagawa, H., Seki, E., Hall, M. N., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.001 · Cited by 183
The dog aging project: translational geroscience in companion animals
Kaeberlein, M., Creevy, K. E., & Promislow, D. E. L. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9638-7 · Cited by 174
The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia
Ham, D. J., Börsch, A., Lin, S., Thürkauf, M., Weihrauch, M., Reinhard, J. R., Delezie, J., Battilana, F., Wang, X., Kaiser, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18140-1 · Cited by 180
How healthy is the healthspan concept?
Kaeberlein, M. (2018) · GeroScience · doi:10.1007/s11357-018-0036-9 · Cited by 176
Longevity, aging and rapamycin
Ehninger, D., Neff, F., & Xie, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1677-1 · Cited by 175
Self-citationRapamycin and Alzheimer’s disease: Time for a clinical trial?
Kaeberlein, M., & Galvan, V. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aar4289 · Cited by 171
Urfer, S. R., Kaeberlein, T. L., Mailheau, S., Bergman, P. J., Creevy, K. E., Promislow, D. E. L., & Kaeberlein, M. (2017) · GeroScience · doi:10.1007/s11357-017-9972-z · Cited by 158
Lesniewski, L. A., Seals, D. R., Walker, A. E., Henson, G. D., Blimline, M. W., Trott, D. W., Bosshardt, G. C., LaRocca, T. J., Lawson, B. R., Zigler, M. C., et al. (2017) · Aging Cell · doi:10.1111/acel.12524 · Cited by 166
mTOR signaling in tumorigenesis
Xu, K., Liu, P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.007 · Cited by 165
Calorie restriction mimetics: Can you have your cake and eat it, too?
Ingram, D. K., & Roth, G. S. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.11.005 · Cited by 161
Turning back time with emerging rejuvenation strategies
Mahmoudi, S., Xu, L., & Brunet, A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0206-0 · Cited by 161
Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases
Ji, S., Xiong, M., Chen, H., Liu, Y., Zhou, L., Hong, Y., Wang, M., Wang, C., Fu, X., & Sun, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01343-5 · Cited by 159
Anti-aging pharmacology: Promises and pitfalls
Vaiserman, A. M., Lushchak, O. V., & Koliada, A. K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.004 · Cited by 151
Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
Arriola Apelo, S. I., Pumper, C. P., Baar, E. L., Cummings, N. E., & Lamming, D. W. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw064 · Cited by 138
Goodman, C. A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_17 · Cited by 160
A toolbox for the longitudinal assessment of healthspan in aging mice
Bellantuono, I., de Cabo, R., Ehninger, D., Di Germanio, C., Lawrie, A., Miller, J., Mitchell, S. J., Navas-Enamorado, I., Potter, P. K., Tchkonia, T., et al. (2020) · Nature Protocols · doi:10.1038/s41596-019-0256-1 · Cited by 145
Self-citationXie, K., Ryan, D. P., Pearson, B. L., Henzel, K. S., Neff, F., Vidal, R. O., Hennion, M., Lehmann, I., Schleif, M., Schröder, S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707337115 · Cited by 134
Self-citationRole of mTORC1 in mechanically induced increases in translation and skeletal muscle mass
Goodman, C. A. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01011.2018 · Cited by 133
Caloric restriction and cancer: molecular mechanisms and clinical implications
Meynet, O., & Ricci, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.001 · Cited by 154
TOR‐mediated regulation of metabolism in aging
Antikainen, H., Driscoll, M., Haspel, G., & Dobrowolski, R. (2017) · Aging Cell · doi:10.1111/acel.12689 · Cited by 122
Does Longer Lifespan Mean Longer Healthspan?
Hansen, M., & Kennedy, B. K. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.05.002 · Cited by 128
Hurez, V., Dao, V., Liu, A., Pandeswara, S., Gelfond, J., Sun, L., Bergman, M., Orihuela, C. J., Galvan, V., Padrón, Á., et al. (2015) · Aging Cell · doi:10.1111/acel.12380 · Cited by 128
Cellular reprogramming and epigenetic rejuvenation
Simpson, D. J., Olova, N. N., & Chandra, T. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01158-7 · Cited by 126
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
Richardson, A., Galvan, V., Lin, A.-L., & Oddo, S. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.12.002 · Cited by 125
Caloric restriction: Beneficial effects on brain aging and Alzheimer’s disease
Van Cauwenberghe, C., Vandendriessche, C., Libert, C., & Vandenbroucke, R. E. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9647-6 · Cited by 121
Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01680-x · Cited by 118
Self-citationEbert, S. M., Dyle, M. C., Bullard, S. A., Dierdorff, J. M., Murry, D. J., Fox, D. K., Bongers, K. S., Lira, V. A., Meyerholz, D. K., Talley, J. J., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681445 · Cited by 120
Biochemical Genetic Pathways that Modulate Aging in Multiple Species: Figure 1.
Bitto, A., Wang, A. M., Bennett, C. F., & Kaeberlein, M. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025114 · Cited by 135
mTOR, cardiomyocytes and inflammation in cardiac hypertrophy
Xu, L., & Brink, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.003 · Cited by 119
Every-other-day feeding extends lifespan but fails to delay many symptoms of aging in mice
Xie, K., Neff, F., Markert, A., Rozman, J., Aguilar-Pimentel, J. A., Amarie, O. V., Becker, L., Brommage, R., Garrett, L., Henzel, K. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00178-3 · Cited by 112
Self-citationMartínez-Cisuelo, V., Gómez, J., García-Junceda, I., Naudí, A., Cabré, R., Mota‐Martorell, N., Lopez‐Torres, M., González-Sánchez, M., Pamplona, R., & Barja, G. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.08.002 · Cited by 114
Tissue Depletion of Taurine Accelerates Skeletal Muscle Senescence and Leads to Early Death in Mice
Ito, T., Yoshikawa, N., Inui, T., Miyazaki, N., Schaffer, S. W., & Azuma, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107409 · Cited by 110
Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation
Martínez‐Vicente, M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.03.005 · Cited by 123
Goldberg, E. L., Romero‐Aleshire, M. J., Renkema, K. R., Ventevogel, M. S., Chew, W. M., Uhrlaub, J. L., Smithey, M. J., Limesand, K. H., Sempowski, G. D., Brooks, H. L., et al. (2015) · Aging Cell · doi:10.1111/acel.12280 · Cited by 102
Unraveling female reproductive senescence to enhance healthy longevity
Dong, L., Teh, D. B. L., Kennedy, B. K., & Huang, Z. (2023) · Cell Research · doi:10.1038/s41422-022-00718-7 · Cited by 101
Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction
Xu, M., Tchkonia, T., & Kirkland, J. L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.015 · Cited by 99
“It was shown to extend lifespan in mice (43), while it had limited effects on age-related tissue dysfunction (44).”
Why is the dog an ideal model for aging research?
Gilmore, K. M., & Greer, K. A. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.08.008 · Cited by 109
Chambers, E. S., Vukmanovic-Stejic, M., Shih, B. B., Trahair, H., Subramanian, P., Devine, O. P., Glanville, J., Gilroy, D., Rustin, M. H. A., Freeman, T. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-020-00010-6 · Cited by 96
Exosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cells
Bi, Y., Qiao, X., Cai, Z., Zhao, H., Ye, R., Liu, Q., Gao, L., Liu, Y., Liang, B., Liu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.11.013 · Cited by 107
Intestinal Amino Acid Transport and Metabolic Health
Bröer, S. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061121-094344 · Cited by 114
The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging
Zhang, Y., Zhang, J., & Wang, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101376 · Cited by 92
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
Johnson, S. C., Yanos, M. E., Bitto, A., Castanza, A., Gagnidze, A., Gonzalez, B., Gupta, K., Hui, J., Jarvie, C., Johnson, B. M., et al. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00247 · Cited by 91
Yang, J., Zhou, X., Fan, X., Xiao, M., Yang, D., Liang, B., Dai, M., Shan, L., Lu, J., Lin, Z., et al. (2016) · Blood · doi:10.1182/blood-2015-10-672964 · Cited by 91
Tuberous sclerosis complex–mediated mTORC1 overactivation promotes age-related hearing loss
Fu, X., Sun, X., Zhang, L., Jin, Y., Chai, R., Yang, L., Zhang, A., Liu, X., Bai, X., Li, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98058 · Cited by 98
Interventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A., Mladenovic Djordjevic, A., Lopez-Contreras, A., Henriques, C. M., Selman, C., Ferreiro, E., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87
Salas-Ramirez, K. Y., Bagnall, C., Frias, L., Abdali, S. A., Ahles, T. A., & Hubbard, K. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.028 · Cited by 97
mTOR-dependent translation amplifies microglia priming in aging mice
Keane, L., Antignano, I., Riechers, S.-P., Zollinger, R., Dumas, A. A., Offermann, N., Bernis, M. E., Russ, J., Graelmann, F., McCormick, P. N., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci132727 · Cited by 86
Metabolic Communication and Healthy Aging: Where Should We Focus Our Energy?
Smith, H. J., Sharma, A., & Mair, W. B. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.011 · Cited by 84
Measures of Healthspan as Indices of Aging in Mice—A Recommendation
Richardson, A., Fischer, K. E., Speakman, J. R., de Cabo, R., Mitchell, S. J., Peterson, C. A., Rabinovitch, P., Chiao, Y. A., Taffet, G., Miller, R. A., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv080 · Cited by 81
“For example, rapamycin, which increases lifespan in both male and female mice in several genetic backgrounds (15–17) results in an increased incidence of testicular degeneration (15,18), elevated insulin resistance (16), and increased cataract formation in one study (18), but not in another study (15).”
BackgroundRapamycin extends life- and health span because it slows aging
Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100591 · Cited by 81
Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
Kleinert, M., Sylow, L., Fazakerley, D. J., Krycer, J. R., Thomas, K. C., Oxbøll, A.-J., Jordy, A. B., Jensen, T. E., Yang, G., Schjerling, P., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.06.004 · Cited by 81
Popovich, I. G., Anisimov, V. N., Zabezhinski, M. A., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., & Blagosklonny, M. V. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28164 · Cited by 79
Leontieva, O. V., Paszkiewicz, G. M., & Blagosklonny, M. V. (2014) · Aging Cell · doi:10.1111/acel.12211 · Cited by 78
Rapamycin treatment attenuates age-associated periodontitis in mice
An, J. Y., Quarles, E. K., Mekvanich, S., Kang, A., Liu, A., Santos, D., Miller, R. A., Rabinovitch, P. S., Cox, T. C., & Kaeberlein, M. R. (2017) · GeroScience · doi:10.1007/s11357-017-9994-6 · Cited by 85
Fischer, K. E., Gelfond, J. A. L., Soto, V. Y., Han, C., Someya, S., Richardson, A., & Austad, S. N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126644 · Cited by 75
Cancer prevention with rapamycin
Blagosklonny, M. V. (2023) · Oncotarget · doi:10.18632/oncotarget.28410 · Cited by 79
The role of the TOR pathway in mediating the link between nutrition and longevity
Lushchak, O., Strilbytska, O., Piskovatska, V., Storey, K. B., Koliada, A., & Vaiserman, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.005 · Cited by 73
Regulation of metabolic health and aging by nutrient-sensitive signaling pathways
Cummings, N. E., & Lamming, D. W. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.014 · Cited by 73
ATF 4 activity: a common feature shared by many kinds of slow‐aging mice
Li, W., Li, X., & Miller, R. A. (2014) · Aging Cell · doi:10.1111/acel.12264 · Cited by 71
André, V., Gau, C., Scheideler, A., Aguilar‐Pimentel, J. A., Amarie, O. V., Becker, L., Garrett, L., Hans, W., Hölter, S. M., Janik, D., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005019 · Cited by 74
Self-citationGH and ageing: Pitfalls and new insights
Bartke, A., & Darcy, J. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.005 · Cited by 70
A paternal methyl donor-rich diet altered cognitive and neural functions in offspring mice
Ryan, D. P., Henzel, K. S., Pearson, B. L., Siwek, M. E., Papazoglou, A., Guo, L., Paesler, K., Yu, M., Müller, R., Xie, K., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.53 · Cited by 69
Self-citationSelenium Deficiency Is Associated with Pro-longevity Mechanisms
Yim, S. H., Clish, C. B., & Gladyshev, V. N. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.001 · Cited by 75
Berberine suppresses gero-conversion from cell cycle arrest to senescence
Zhao, H., Halicka, H. D., Li, J., & Darżynkiewicz, Z. (2013) · Aging · doi:10.18632/aging.100593 · Cited by 74
Rapamycin-induced metabolic defects are reversible in both lean and obese mice
Liu, Y., Diaz, V., Fernandez, E., Strong, R., Ye, L., Baur, J. A., Lamming, D. W., Richardson, A., & Salmon, A. B. (2014) · Aging · doi:10.18632/aging.100688 · Cited by 68
“Chronic rapamycin treatment has been shown to slow the progression of some, but not all, of the physiological declines associated with mouse aging [12-14].”
BackgroundeRapa Restores a Normal Life Span in a FAP Mouse Model
Hasty, P., Livi, C. B., Dodds, S. G., Jones, D., Strong, R., Javors, M., Fischer, K. E., Sloane, L., Murthy, K., Hubbard, G., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0299 · Cited by 68
The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop
Budinger, G. S., Kohanski, R. A., Gan, W., Kobor, M. S., Amaral, L. A., Armanios, M., Kelsey, K. T., Pardo, A., Tuder, R., Macian, F., et al. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx090 · Cited by 68
Metadata
- Authors
- Neff, F., Flores-Dominguez, D., Ryan, D. P., Horsch, M., Schröder, S., Adler, T., Afonso, L. C., Aguilar-Pimentel, J. A., Becker, L., Garrett, L., Hans, W., Hettich, M. M., Holtmeier, R., Hölter, S. M., Moreth, K., Prehn, C., Puk, O., Rácz, I., Rathkolb, B., Rozman, J., Naton, B., Ordemann, R., Adamski, J., Beckers, J., Bekeredjian, R., Busch, D. H., Ehninger, G., Graw, J., Höfler, H., Klingenspor, M., Klopstock, T., Ollert, M., Stypmann, J., Wolf, E., Wurst, W., Zimmer, A., Fuchs, H., Gailus-Durner, V., Hrabe de Angelis, M., & Ehninger, D.
- Affiliations
- Helmholtz Munich (DE)
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Münster (DE)
- University of Bonn (DE)
- University Hospital Carl Gustav Carus (DE)
- Heidelberg University (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- Max Planck Society (DE)
- Corresponding author
- Ehninger, Dan
- ORCID
- Ryan, Devon P.
- Adler, Thure
- Becker, Lore
- Garrett, Lillian
- Hans, Wolfgang
- Hettich, Moritz M.
- Hölter, Sabine M.
- Moreth, Kristin
- Prehn, Cornelia
- Puk, Oliver
- Rácz, Ildikó
- Rathkolb, Birgit
- Rozman, Jan
- Adamski, Jerzy
- Beckers, Johannes
- Bekeredjian, Raffi
- Busch, Dirk H.
- Ehninger, Gerhard
- Graw, Jochen
- Klingenspor, Martin
- Klopstock, Thomas
- Ollert, Markus
- Wolf, Eckhard
- Wurst, Wolfgang
- Zimmer, Andreas
- Fuchs, Helmut
- Ehninger, Dan
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-25
- Volume
- 123
- Issue
- 8
- Pages
- 3272-3291
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726163
- OpenAlex
- W2025133084
- Cited by
- 374
- References
- 58
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 16 · 2023: 22 · 2022: 17 · 2021: 32 · 2020: 19 · 2019: 24 · 2018: 28 · 2017: 20 · 2016: 41 · 2015: 58 · 2014: 48 · 2013: 13
- FWCI
- 18.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- rapamycin, lifespan extension, aging, mTOR inhibition, age-related phenotypes, longevity, C57BL/6J mice
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Drug Evaluation, Preclinical, Granuloma, Immunoglobulins, Leukocyte Count, Liver, Liver Cirrhosis, Longevity, Male, Mice, Inbred C57BL, Oxygen Consumption, Phenotype, Platelet Count, Psychomotor Performance, T-Lymphocytes, Thyroid Gland, Survival Analysis, Maze Learning, Sirolimus, Mice, Muscle Strength, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.